Comparing two versions of a fertility drug in healthy women
This study tests if a new version of a fertility drug (KM04) works like the standard version (Gonal-f) by giving healthy women either one and checking safety and how the body handles it. Participation lasts several weeks and involves taking birth control pills and daily injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old.
- You are generally healthy with no significant medical conditions.
- Your weight is at least 45 kg (about 99 lbs) and your BMI is between 18 and 30.
- You have a history of regular menstrual cycles (24-35 days) and have both ovaries.
- You are willing to take birth control pills and receive injections as part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new injected hormone (SJ04) with a standard one (Ovidrel) to see if they work similarly. It's for healthy women with regular cycles who might need help with fertility treatments.
This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This trial tests whether a lower or higher dose of follicle-stimulating hormone (FSH) works better for women with normal egg supply. If you are starting your first or second IVF cycle, you may be able to join.
This trial compares two starting doses of follicle-stimulating hormone (FSH) during in vitro fertilization (IVF) to see which works better. FSH helps your ovaries produce eggs, and the study aims to find the best dose for women with good fertility prospects.
This study tests how safe and tolerable a new drug, KSHN001034, is in healthy women who have gone through menopause. It involves multiple doses to see how your body processes the medicine.
Hear when a new Healthy Female Adult Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.